Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Steroid Resistant Grade II to IV GVHD by Infusion MSCof Mesenchymal Stem Cells Expanded With Human Plasma and Platelet Lysate a Phase I/II Study

NCT00827398 is registered in ClinicalTrials.gov with N.M. Wulffraat as lead sponsor.

NCT NCT00827398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00827398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Steroid Resistant Grade II to IV GVHD by Infusion MSCof Mesenchymal Stem Cells Expanded With Human Plasma and Platelet Lysate a Phase I/II Study
Lead sponsor
N.M. Wulffraat
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2013
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host-disease